Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia

NCT00021151 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: alemtuzumab

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]